ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 285,86
-0,60%
Dow Jones
38 170,41
-2,48%
DAX
21 205,86
-0,52%
Brent Oil
65,81
-1,89%
Bitcoin
87 360,68
2,56%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) Actualités

FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FOLD
DateHeureSourceTitreSymboleSociété
21/04/202513h00GlobeNewswire Inc.Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025NASDAQ:FOLDAmicus Therapeutics Inc
18/03/202522h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
27/02/202513h00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025NASDAQ:FOLDAmicus Therapeutics Inc
21/02/202522h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
21/02/202522h03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FOLDAmicus Therapeutics Inc
19/02/202522h38Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:FOLDAmicus Therapeutics Inc
19/02/202522h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
19/02/202522h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FOLDAmicus Therapeutics Inc
19/02/202513h00GlobeNewswire Inc.Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202502h00Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
10/02/202513h00GlobeNewswire Inc.Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025NASDAQ:FOLDAmicus Therapeutics Inc
03/02/202513h00GlobeNewswire Inc.Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025NASDAQ:FOLDAmicus Therapeutics Inc
30/01/202511h07Business WireAmicus Therapeutics Launches Amicus Ignite, a Proactive Community Funding Programme for Initiatives That Support People Living With Pompe DiseaseNASDAQ:FOLDAmicus Therapeutics Inc
12/01/202522h00GlobeNewswire Inc.Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic OutlookNASDAQ:FOLDAmicus Therapeutics Inc
02/01/202513h00GlobeNewswire Inc.Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
15/11/202403h00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
14/11/202417h37Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:FOLDAmicus Therapeutics Inc
06/11/202422h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FOLDAmicus Therapeutics Inc
06/11/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
01/11/202412h00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024NASDAQ:FOLDAmicus Therapeutics Inc
28/10/202412h00GlobeNewswire Inc.Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:FOLDAmicus Therapeutics Inc
17/10/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with TevaNASDAQ:FOLDAmicus Therapeutics Inc
04/10/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024NASDAQ:FOLDAmicus Therapeutics Inc
03/09/202413h46GlobeNewswire Inc.UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024NASDAQ:FOLDAmicus Therapeutics Inc
03/09/202413h05GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024NASDAQ:FOLDAmicus Therapeutics Inc
03/09/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual SymposiumNASDAQ:FOLDAmicus Therapeutics Inc
08/08/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
30/07/202413h00GlobeNewswire Inc.Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:FOLDAmicus Therapeutics Inc
07/06/202422h38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FOLDAmicus Therapeutics Inc
05/06/202413h00GlobeNewswire Inc.Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FOLD

Dernières Valeurs Consultées

COIN
BIDSUSD
DeFi Bids
USOTC
MHVYF
Mitsubishi Heavy Industr... (PK)
USOTC
ENGGY
Enagas (PK)
COIN
RUSDETH
Realio Network USD Stablecoin
COIN
TRBTETH
Tribute
USOTC
AJLGF
AJ Lucas (PK)
NASDAQ
GNTX
Gentex
EU
BISWN
EN BIODIV SCR W NR 4 17535
LSE
0IYQ
Gogo
AQSE
GDLF
Good Life Plus
BIT
USSMC
ETF
BIT
1CHTR
Charter Communications
BIT
BTP10
Etf
EU
FFARM
Forfarmers NV
AMEX
XOP
SPDR S&P Oil and Gas Exp...
BIT
1VRTX
Vertex Pharmac Dl 01
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces